ERYTHRODERMA. ASAPA 2018 Fall Conference Tucson, AZ 10/12/2018. Andrew Newman, DO Pgy-3, Affiliated Dermatology/Honor Health

Similar documents
Psoriasiform Dermatitis in Children: Calling in the Troops

Recalcitrant Warty Erythroderma With Severe Pruritus. Gil Yosipovitch Professor & Chair Department of Dermatology & Itch Center Temple University

Psoriasis. Jessica Kaffenberger, M.D. Assistant Professor of Dermatology Division of Dermatology The Ohio State University Wexner Medical Center

U059 Hidradeni-s Suppura-va and Pityriasis Rubra Pilaris: Updates on Treatment

S003 CPC Self-Assessment

DERMATOLOGICAL EMERGENCIES. DR. Ian Hoyle MBBS DIP IMC RCS (Ed), DA (UK),FRACGP,FACRRM,DIP DERM(Wales) TASMANIAN SKIN AND BODY CENTRE

Rayos Prior Authorization Program Summary

Emergency Dermatology Dr Melissa Barkham

Skin Manifestations of Drug Reactions

Phototherapy and Photochemotherapy Treatment (Ultraviolet A [PUVA] and B [UBV])

Drug allergy and Skin Disorders. Timothy Craig, DO, FACOI Professor of Medicine and Pediatrics Distinguished Educator Penn State University, Hershey

chemotherapeutic agents in

Atopic Dermatitis and Topical Antipsoriatics

Psoriasis management. A/Prof Amanda Oakley Dermatologist, Waikato

Cluster of differentiation (CD) markers in erythrodermic patients: A case series study

The Natural History of Psoriasis and Treatment Goals

A Case of Erythrodermic Dermatomyositis Associated with Gastric Cancer

ISPUB.COM. Bexarotene in Tumor stage Mycosis Fungoides. R Talpur, M Duvic INITIAL PRESENTATION TREATMENT COURSE INTRODUCTION

Carolyn Bangert, MD Associated Dermatologists, PC

Allergic Emergencies and Anaphylaxis. George Porfiris MD, CCFP(EM),FCFP TEGH

Patching the Gaps in Our Diagnostic Knowledge. By Tyler Hooton MS3 UWSOM

See Important Reminder at the end of this policy for important regulatory and legal information.

Cutanous Manifestation of Lupus Erythematosus. Presented By: Dr. Naif S. Al Shahrani Salman Bin Abdaziz university

A Retrospective Study of Correlation Between Clinical And Histopathological Diagnosis In Erythroderma.

Melanoma Immunotherapy. Nursing Perspective on Immune-Related Adverse Events: Patient education, Monitoring & Management

RHEUMATOLOGY OVERVIEW. Carmelita J. Colbert, MD Assistant Professor of Medicine Division of Rheumatology Loyola University Medical Center

Ustekinumab Treatment of Erythrodermic Psoriasis Occurring after Physical Stress: A Report of Two Cases

Psoriasiform pemphigus foliaceus: a report of two cases

COMMON SKIN CONDITIONS IN PRIMARY CARE. Ibrahim M. Zayneh, MD Dermatology Private Practice, Portsmouth, Ohio

What to do when patch testing is negative?

REGISTRY OF SEVERE CUTANEOUS ADVERSE REACTIONS TO DRUGS AND COLLECTION OF BIOLOGICAL SAMPLES. R e g i S C A R PATIENT'S DATA. Age country of birth

Medication Policy Manual. Topic: Dupixent, dupilumab Date of Origin: March 10, Committee Approval: March 10, 2017 Next Review Date: May 2018

Case Presentation: Mr. S

SJS/TEN spectrum. Stevens-Johnson syndrome (SJS) /Toxic Epidermal Necrolysis (TEN) 10/7/2016

Emergent and Urgent Dermatology, Eruptions, and Wound Care

Contact Dermatitis In Atopic Patients

1. Background: Infliximab is administered parenterally; therefore, it is not covered under retail pharmacy benefits.

UPDATE IN HOSPITAL MEDICINE

Clinical, Histopathological and Immunohistochemical Study of Cases Presenting with Erythroderma

What is atopic dermatitis?

Skin Deep: Or is It? Practical Pearls from a Pediatric Dermatologist

ERYTHRODERMA CAUSED DRUG ALLERGIES

Rheumatoid arthritis and Psoriatic arthritis: a guide for Primary Care. Nina Flavin, MD Rheumatology Confluence Health April 13 th, 2018

Difference Between Seborrheic Dermatitis and Psoriasis

Nephrotic Syndrome. Sara Alsharhan PharmD candidate, KSU 2014

The many faces of myositis. Marianne de Visser Academic Medical Centre Dept of Neurology Amsterdam The Netherlands

Writing with purpose. Make IT real and simple. On the Medicine Wards for Medical Students, Interns, and Residents

Dose of prednisone for allergic reaction

A Pilot Study. Name of investigational product:

Case 1. Debridement Cultures Keflex Silvadene

Eczema & Dermatitis Clinical features: Histopathological features: Classification:

Objectives. 3HP and Flu Syndrome What is the Underlying Mechanism? Case #1 3/23/2016. Christina T. Fiske, MD MPH March 30, 2016

Allogeneic Stem Cell Transplantation for Cutaneous T-cell Lymphoma: Updated results from a single center

What s Topical About Topicals?

Optimal Itch Management

Dermatology GP Referral Guidelines

Do not take this question paper out of the examinations room. Do not turn over until you are told to do so by the Invigilator.

BGS Spring Conference 2015

Monitoring Patients on Biologic Therapies Murlidhar Rajagopalan, MBBS, MD

A48-year-old Hispanic woman

Exfoliative Erythroderma

Atopic Dermatitis and Primary Immunodeficiency: When Should I Worry?

Topical Calcipotriol Algorithm

4 th Annual SKIN: Practical Dermatology for the Generalist Program Schedule

Kohlman Evaluation of Living Skills (KELS) of the Hospitalized Patient. Family Medicine Residency Program at Wesley. Objectives

Learning Circle: Jan 26, 2011 Childhood Eczema

Michael P. Heffernan, M.D San Luis Dermatology & Laser Clinic Director, US Probity Medical Research

Psoriasis. Andrei Metelitsa, MD, FRCPC, FAAD Clinical Associate Professor, Dermatology, U of C Co-Director, Institute for Skin Advancement

Sepsis Combine experience and Evidence. Eran Segal, MD Director General ICU, Sheba Medical Center, Israel

Rashes Not To Be Missed In Children

Endocarditis. By : Mehrnoush. dianatkhah

Patient Leaflet : Information for the user Locoid Cream 0.1% w/w Hydrocortisone butyrate

HIV-Dermatology Concepts in 2011

Nephrology Grand Rounds. Mansi Mehta November 24, 2015

An Everyday Guide to Eczema

44 year-old male. Follicular Hyperkeratosis 3/4/2019. Clinical: Erythematous scaling papules symmetrically on the forearms, abdomen and lower back

Citywide Infectious Disease Conference. March 27 th, 2018

Dermatology Pearls. Leah Layman, ARNP Jefferson Healthcare Dermatology June 21, 2018

Drugs and Applicable Coding: J-code: Enbrel-J1438; Humira-J0135; Remicade-J1745; Inflectra-Q5102; Cimzia-J0718; Simponi-J1602 Renflexis - pending

PRE-RENAL AKI: DOES IT LEAD TO ATN. Sushma Bhusal

Clinical Policy: Phototherapy and Photochemotherapy for Dermatological Conditions Reference Number: CP.MP. 441

COPD and Asthma: Similarities and differences Prof. Peter Barnes

Pityriasis rubra pilaris: Not just skin deep a case series

Dermclinic

PART IV: NEUROPATHIC PAIN SYNDROMES JILL SINDT FEBRUARY 7, 2019

Dermatology elective for yr. 5. Natta Rajatanavin, MD. Div. of dermatology Dep. Of Medicine, Ramathibodi Hospital Mahidol University 23 rd Feb 2015

Psoriasis. What is Psoriasis? What causes psoriasis? Medical Topics Psoriasis

GOOD MORNING! Thursday, July Heidi Murphy, MD Leslie Carter-King, MD

Nursing Perspective on iraes: Patient Education, Monitoring and Management

3rd Annual SKIN: Practical Dermatology for the Generalist Program Schedule

Treatments used Topical including cleansers and moisturizer Oral medications:

Dermatology for the Internist Alabama and Mississippi ACP Scientific Meeting 2017

What s causing this rash?

Case #1. 73 y/o man with h/o HTN and CHF admitted with dizziness and SOB Treated for CHF exacerbation with Lasix Now HR 136

Long-term ustekinumab treatment for refractory type I pityriasis rubra pilaris

Best Practices Pearls

Psoriasis is a chronic, inflammatory, Prescribing in children

AN2728 Clinical Data in Atopic Dermatitis

Dermatology for the frontline

Transcription:

ERYTHRODERMA ASAPA 2018 Fall Conference Tucson, AZ 10/12/2018 Andrew Newman, DO Pgy-3, Affiliated Dermatology/Honor Health

OBJECTIVES Define Erythroderma Name common diseases and medications that cause erythroderma Explain morbitidy in erythrodermic patients Discuss the initial management of the erythrodermic patient Cases Take-home points

DEFINE ERYTHRODERMA A generalized redness and/or scaling of at least 90% of Body Surface Area (BSA)

Erythroderma is NOT a specific diagnosis COMMON CAUSES OF ERYTHRODERMA Drug (40%) Antibiotics, calcium channel blockers, allopurinol, lithium, anti-epileptics Psoriasis (20%) Idiopathic (10%) Eczema/atopic dermatitis (10%) Lymphoma/mycosis fungoides (10%) Others: Dermatomyositis (DM), Seborheic Dermatitis, Contact dermatitis, Pytiariasis Rubra Pilaris (PRP) ***Percentages vary between sources

ERYTHRODERMA MORBIDITY Complications include sepsis and high-output heart failure Dehydration and electrolyte abnormalities Cardiorespiratory decompensation Hospitalization may be necessary Dermatology consult is essential

NO MATTER WHAT THE CAUSE IS INITIAL MANAGEMENT Remove potential offending/unnecessary medications Address fluids and electrolytes Wet dressings and topical steroids (like TAC)

CASE ONE CL is a 64 yo man presenting to the dermatology clinic with a rapid progression of redness covering most of his body. He recently was discharged from the hospital after an acute exacerbation of COPD, where he was treated with Levaquin and IV corticosteroids. PMH: COPD, HTN, Dyslipidemia, psoriasis Meds: Resp inhalers, ACE inhibitor, statin, topical Clobetasol Allergies: none FH: heart disease and psoriasis and hypothyroidism SH: tobacco user. No recreational drugs/etoh ROS: fatigue

Vitals: T 100.4, BP 98/70, HR 120, RR 16, O2 97% Not acutely distressed Diffuse redness and silver scale CASE ONE CONT

WHAT IS THE MOST LIKELY DIAGNOSIS? A). Cutaneous T-cell Lymphoma B). Idiopathic C). Psoriatic erythroderma D). Atopic dermatitis

WHAT IS THE MOST LIKELY DIAGNOSIS? A). Cutaneous T-cell Lymphoma B). Idiopathic C). Psoriatic erythroderma D). Atopic dermatitis

ERYTHRODERMIC PSORIASIS PMH and/or FH of psoriasis Acute or subacute onset following: Emotional stress Medication Infection DISCONTINUATION OF PSORIASIS TREATMENT (PREDNISONE) Treatment: Potent topical steroids MTX or biologic (ie. anti-tnf)

ERYTHRODERMIC PSORIASIS WORK UP Total IgE, CBC/CMP, CRP, ANA w/ reflex ab panel, rapid strep (help with diagnosis) Cocci titers, Quantiferon, Hep panel, HIV (all for anticipating initiation of biologic) Two skin biopsies Start topical betamethasone augmented cream and discuss adalimumab for near future.

CASE TWO NS is a 52 yo man admitted for a full-body rash. His rash had slowly progressed over 2 years prior to dramatically worsening over the past week. The man had admitted to having multiple skin biopsies in the past which were inconclusive. He was started on IV fluids and broad spectrum antibiotics for presumed sepsis. Dermatology was consulted. PMH: Cerebral Vascular Accident and Traumatic Brain Injury Meds: Baby aspirin, topical triamcinolone cream Allergies: none FH: none SH: on disability from CVA ROS: Diffuse itchiness

Vitals: T 100.1, BP 98/70, HR 108, RR 18, O2 96% Not acutely distressed Diffuse redness, lion-like face, thickened skin. CASE 2 CONT

WHAT IS THE MOST LIKELY DIAGNOSIS? A). Cutaneous T-cell Lymphoma B). Drug-induced C). Psoriatic erythroderma D). Atopic dermatitis

WHAT IS THE MOST LIKELY DIAGNOSIS? A). Cutaneous T-cell Lymphoma (ie. mycosis fungoides/sezzary syndrome) (Thick lion-like facial skin, hx of multiple non-specific skin bxs) B). Drug-induced (no new/suspect drugs, not acute, initial hive-like rash or morbilliform-like rash) C). Psoriatic erythroderma (no thicken silver scale, no nail findings, no FH/PMH of psoriasis) D). Atopic dermatitis (no hx of eczema/asthma/allergy rhinitis)

MYCOSIS FUNGOIDES (MF) Most common form of Cutaneous T-Cell Lymphoma Sezzary Syndrome (SS) is MF plus numerous abnormal sezzary cells in serum MF/SS can cause erythroderma with thickened skin and lionlike facies Often involves hands and feet May spare the skin folds Skin biopsies COULD help in dx Peripheral blood smear to dx SS.

MF/SS WORK-UP/TREATMENT IgE, CBC/CMP, CRP, ANA w/ reflex ab panel SPEP, UPEP Three 4mm punch biopsies of skin Stat peripheral blood smear x2 (Pt was positive for many Sezzary cells) CALL HEME/ONC Topical triamcinolone cream, hydroxyzine ATC, 14 days of Keflex to prevent secondary infections, heme/onc to do chemotherapy.

REFERENCES 1. Bruno TF, Grewal P. Erythroderma: a dermatologic emergency. CJEM. 2009; 11:244-6 2. Grant-Kels Jane M, Bernstein Megan L, Rothe Marti J, Chapter 23. Exfoliative Dermatitis (Chapter). Wolff K, Goldsmith LA, Katz SI, Gillchrest B, Paller AS, Leffell DJ: Fitzpatrick s Dermatology in General Medicine, 7e.